GHO sells BioAgilytix to Cinven
- GHO Capital and Cobepa, a Brussels-based private investment firm, first backed BioAgilytix in November 2018.
- Cinven will acquire a majority stake in the business, while current majority investor Cabepa will remain a significant minority investor in the company. ...